pre-IPO PHARMA

silicon-therapeutics PRESS RELEASE ARCHIVE

Feb 26, 2021

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics


Feb 26, 2021

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics


Dec 10, 2020

Silicon Therapeutics Announces Members of Scientific Advisory Board


Nov 23, 2020

Silicon Therapeutics Announces Dosing of First Patient in Phase 1 Open-Label Clinical Trial of SNX281 for Advanced Solid Tumors or Lymphoma


Oct 21, 2020

Silicon Therapeutics Supports Five Researchers Through Open Science Fellows Program



Oct 6, 2020

Silicon Therapeutics Unveils Refreshed Corporate Branding and Redesigned Website


Aug 4, 2020

Silicon Therapeutics Appoints Pamela Carroll, Ph.D. as Chief Business Officer


Jan 6, 2020

Silicon Therapeutics Expands Leadership Team with Key Appointments in Clinical Development and Strategy as well as Computational Physics


Jul 8, 2019

Silicon Therapeutics Expands Board by Naming Roger J. Pomerantz, MD, FACP as Chairman of the Board of Directors and Appointing Mark J. Gilbert, MD as a Board Director


Oct 16, 2017

Silicon Therapeutics Appoints Dr. Christopher Winter as Chief of RandD



Jun 29, 2017

Silicon Therapeutics Appoints Todd J. Martinez, Ph.D to Scientific Advisory Board


May 26, 2017

Silicon Therapeutics Announces Recipient of the First Open Science Fellowship


Mar 24, 2017

Woody Sherman Ph.D, Joins Silicon Therapeutics as CSO, Leading Efforts on Platform Development and Drug Design


Google Analytics Alternative